Delisting riskPopularity #3,846
Heron Therapeutics (HRTX)
Sells U.S. hospital injectables for postsurgical pain and nausea prevention.
$0.2893
vs last close−0.01 (−3.24%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 70.97% | 134.74M shares | |
|---|---|---|---|
| 170 holders · as of Jun 30, 2026 | |||
| Insiders | 1.07% | 2.03M shares | |
| 11 holders · as of Aug 10, 2026 | |||
| Other | 27.96% | 53.08M shares | |
| remainder | |||
189.85M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
170 holders · 134.74M shares · 24 new positions · 82 increased · 39 reduced · 26 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Rubric Capital Management LP | 30.05M | 15.83% | 0 | Aug 14, 2026 |
| Clearline Capital LP | 11.38M | 6.00% | −851.3K | Aug 14, 2026 |
| BlackRock, Inc. | 10.55M | 5.56% | +444.3K | Aug 7, 2026 |
| Velan Capital Investment Management LP | 8.75M | 4.61% | 0 | Aug 14, 2026 |
| Vanguard Capital Management LLC | 7.78M | 4.10% | −27.6K | Aug 13, 2026 |
| Tejara Capital Ltd | 6.51M | 3.43% | +174.0K | Aug 11, 2026 |
| Tang Capital Management LLC | 6.25M | 3.29% | 0 | Aug 14, 2026 |
| Geode Capital Management, LLC | 4.27M | 2.25% | +260.9K | Aug 12, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Rubric Capital Management LPincl. David Rosen | 15.90% | 30.05M | 13D | Oct 17, 2025 |
| Clearline Capital LP | 6.70% | 12.24M | 13G | Feb 17, 2026 |
| Adage Capital Management, L.P.incl. Robert Atchinson, Phillip Gross | 5.84% | 8.85M | 13G | Nov 12, 2024 |
| BlackRock, Inc. | 5.60% | 8.53M | Oct 24, 2024 |
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.